New RSV protections for infants hit cost, insurance hurdles in U.S. rollout

Pfizer’s maternal vaccine, Abrysvo, and Sanofi’s monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this...

Related Keywords

California ,United States ,Dallas ,Texas ,Ohio ,Cincinnati ,New York ,Sanofi Beyfortus ,Kelly Parsons ,Graham Bakke ,Erin Bakke ,James Watson ,Michael Chamberlin ,Laura Riley ,Blue Cross Shield Association ,Pfizer ,Pediatric Associates Of Mt ,Southern California ,Pediatric Associates ,Weill Cornell Medicine ,New York Presbyterian ,News ,